Get the Stockscreener App
6.14
4.60%
0.27
Entrada Therapeutics Inc stock is traded at $6.14, with a volume of 198.84K.
It is up +4.60% in the last 24 hours and down -3.76% over the past month.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
See More
Previous Close:
$5.87
Open:
$5.89
24h Volume:
198.84K
Relative Volume:
1.12
Market Cap:
$233.55M
Revenue:
$239.40M
Net Income/Loss:
$104.44M
P/E Ratio:
2.0743
EPS:
2.96
Net Cash Flow:
$-18.50M
1W Performance:
+16.51%
1M Performance:
-3.76%
6M Performance:
-52.91%
1Y Performance:
-61.89%
1-Day Range:
$5.8701
$6.27
1-Week Range:
$5.23
$6.27
52-Week Range:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Name
Entrada Therapeutics Inc
Sector
Industry
Phone
857-305-1825
Address
ONE DESIGN CENTER PLACE, BOSTON
Compare TRDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
6.14 | 209.96M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Jan-05-24 | Initiated | Oppenheimer | Outperform |
| Apr-03-23 | Initiated | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Stock (TRDA) Latest News
Applying chart zones and confluence areas to Entrada Therapeutics Inc.Weekly Market Summary & Fast Momentum Stock Entry Tips - Newser
Predicting Entrada Therapeutics Inc. trend using moving averagesMarket Movers & Proven Capital Preservation Methods - Newser
Can Entrada Therapeutics Inc. rally from current levelsWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Will a bounce in Entrada Therapeutics Inc. offer an exitJuly 2025 Big Picture & Risk Managed Investment Entry Signals - Newser
Combining price and volume data for Entrada Therapeutics Inc.2025 Risk Factors & Daily Stock Trend Watchlist - Newser
Historical volatility pattern of Entrada Therapeutics Inc. visualized2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Multi asset correlation models including Entrada Therapeutics Inc.2025 Price Momentum & Smart Money Movement Tracker - Newser
Automated trading signals detected on Entrada Therapeutics Inc.2025 Market Overview & Low Drawdown Momentum Ideas - Newser
Will Entrada Therapeutics Inc. see short term momentumProduct Launch & Real-Time Buy Signal Notifications - Newser
Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) PT at $25.67 - Defense World
Volume spikes in Entrada Therapeutics Inc. stock – what they mean2025 Market Overview & Trade Opportunity Analysis - Newser
Is Entrada Therapeutics Inc. stock reversal real or fakeJuly 2025 EndofMonth & Daily Profit Focused Screening - Newser
Is Entrada Therapeutics Inc. still worth holding after the dipJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - Newser
Regression Model Predicts Rangebound Movement in Entrada Therapeutics Inc.Inflation Watch & Reliable Momentum Entry Alerts - beatles.ru
Real time breakdown of Entrada Therapeutics Inc. stock performanceTrade Risk Report & Fast Exit/Entry Strategy Plans - Newser
Sentiment analysis tools applied to Entrada Therapeutics Inc.July 2025 Retail & Safe Swing Trade Setups - Newser
Tools to assess Entrada Therapeutics Inc.’s risk profile2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Can volume confirm reversal in Entrada Therapeutics Inc.Market Volume Report & Advanced Swing Trade Entry Plans - Newser
Is Entrada Therapeutics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Review & High Return Trade Guides - Newser
Quant Models Detect Momentum Reversal in Entrada Therapeutics Inc.Trade Analysis Summary & High Accuracy Swing Entry Alerts - newsyoung.net
Measuring Entrada Therapeutics Inc.’s beta against major indices2025 AllTime Highs & Verified Momentum Stock Alerts - Newser
Entrada Therapeutics Inc. Added to High Probability Setup ListJuly 2025 Final Week & Safe Capital Investment Plans - thegnnews.com
A Quick Look at Today's Ratings for Entrada Therapeutics(TRDA.US), With a Forecast Between $17 to $20 - 富途牛牛
Entrada Therapeutics Inc. recovery potential after sell offJuly 2025 Final Week & Community Consensus Stock Picks - Newser
Can Entrada Therapeutics Inc. disrupt its industryQuarterly Performance Summary & Long Hold Capital Preservation Plans - mustnews.co.kr
What moving averages say about Entrada Therapeutics Inc.2025 Earnings Impact & Technical Entry and Exit Tips - Newser
How Entrada Therapeutics Inc. stock performs during market volatilityFree Accurate Buy Point for Momentum Stocks - Newser
What makes Entrada Therapeutics Inc. stock price move sharplyTrading Opportunities Forecast by AI Insight - Newser
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates - 富途牛牛
HC Wainwright Issues Pessimistic Outlook for TRDA Earnings - Defense World
Roth Capital Issues Pessimistic Forecast for TRDA Earnings - Defense World
Why Entrada Therapeutics Inc. stock attracts strong analyst attentionWeekly Market Direction and Sector Summary - Newser
William Blair Issues Negative Forecast for TRDA Earnings - Defense World
Entrada Therapeutics Inc Stock (TRDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Entrada Therapeutics Inc Stock (TRDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| 5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
20,065 |
150,528 |
3,163,066 |
| 5AM Ventures V, L.P. | 10% Owner |
Jul 09 '25 |
Sale |
7.50 |
6,935 |
52,026 |
1,093,313 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):